about
Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A virusesAcute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptidesStructural and functional characterisation of ferret interleukin-2Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lungInterval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.Limited novel influenza A (H1N1) 09 infection in travelling high-school tour group.Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study.Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients.The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccinationDifferential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009.Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice.Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis.Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral HierarchiesInternational Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEHeterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses.2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.Thymic expression of a gastritogenic epitope results in positive selection of self-reactive pathogenic T cells.Correction: Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral LoadThe role of CD4+ CD25+ immunoregulatory T cells in the induction of autoimmune gastritisEndogenous H/K ATPase -Subunit Promotes T Cell Tolerance to the Immunodominant Gastritogenic DeterminantRequirements for autoimmune responses to mouse gastric autoantigens
P50
Q27663289-46CAFB94-9BB1-4A0C-AC6B-E1C30FE4E033Q27687391-D1807677-1E62-4C94-98B7-B1157851CE60Q27702305-AAFA637D-050B-4256-9B3B-877CE4C9831BQ30357438-9A16F3C3-C670-488C-94D2-E6AD62B29D10Q30363454-488AE02E-41C5-4099-A826-76E7F98F579AQ30373884-B3DBAAA1-8751-4567-AC0A-37C3AE141CD5Q30374400-5DD21E36-4E22-45DD-BD08-376405CF4FB5Q30392698-47FEFDA4-99CE-4B24-B8FF-4646290F6652Q30397104-E611C5F1-3E6D-4ED0-BF34-B2B029C40765Q30397110-760B48EC-2DEC-494A-8512-156D6D4A81EBQ30398642-1ACED2AE-69C3-4F8C-AF36-8BEA28D471C7Q30400161-F3745FB5-E053-4C6C-9FE1-225976359B7AQ30406109-9C0EE11A-6AA8-4491-B1A6-B3757BCA8982Q30406690-179B700F-74E6-41DA-A305-CB7D6C3A9A47Q30416214-775B3888-2E18-4DED-8563-0B7624121E24Q30425925-7EBCC12A-5C70-4ABC-A651-30A8AFA2677EQ30430458-542F5663-2D89-459A-8029-B59D26D69BB7Q30432591-C33C97DF-F893-4762-9309-6BC47D59503AQ33713407-00CAB0C0-25B0-41CB-983B-A85D4C319D86Q34681157-18A5C8DD-12B1-473E-AD67-09159F7E8AC5Q34731272-01E503EE-191E-4AEC-AEB0-B2DAC3E10400Q35172066-E231F6C6-05DF-4159-97EA-FFAE530C3664Q35748822-5AE56B30-F745-414F-A648-FA9DD1400F44Q35901999-9E8B64A2-E0B7-4BA9-BC08-55A4D74EC942Q36251479-AD3345B1-FBB2-4BE1-BCBD-57EDA4499A32Q36570810-C3EC29C1-BD16-4701-8ABC-B2B45AD3759CQ36747588-6D6D4307-9D77-4A97-A800-F5D86DA43E8FQ36760165-7FED886A-16F7-400D-B3AF-C0BA82785F68Q37256687-0445867C-CB5C-41C3-9A0A-01D852C85EB2Q37336804-0E27452F-2F6C-4561-80FE-0CE3170230CDQ40081805-3705AD09-1A97-460F-BDCC-3C02B7A9CC27Q42216579-F5CC2135-77C4-497E-82EF-B565782553CBQ43174219-6BD0AF30-2D8F-4327-93A1-CDAD8D4F6FDBQ47418985-4DF70E97-72D6-4687-A739-3C7A1CF2D48AQ47644515-59B50387-0E12-4E85-B30A-D0B2A6BF3EA5Q57240568-824BD031-B841-4EBA-ADAA-A9CB4C349245Q57240587-4831C36E-ECDA-411C-8E4B-43460D5AA1D6Q57240589-BE2879A5-6A84-4111-82AA-E5E00C6B777AQ57240591-546DE3E9-4BF3-4473-A159-C8FC9250A42B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Karen L Laurie
@ast
Karen L Laurie
@en
Karen L Laurie
@es
Karen L Laurie
@sl
type
label
Karen L Laurie
@ast
Karen L Laurie
@en
Karen L Laurie
@es
Karen L Laurie
@sl
prefLabel
Karen L Laurie
@ast
Karen L Laurie
@en
Karen L Laurie
@es
Karen L Laurie
@sl
P106
P21
P31
P496
0000-0001-5186-8342